Second Sight Medical Products has taken necessary steps to reduce overhead costs and conserve liquidity while assessing strategic options and continuing operations, according to a press release.
Despite positive interim results from six patients implanted with the Orion visual cortical prosthesis system, the company is exploring securing funding, business partnerships, acquisitions, and investing in or combining with other businesses.
“Since taking over as the acting CEO, we have been able to attract interest from unrelated third parties that may enable us to secure value from the
Uncategorized